Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
JAMA
|
December 14, 2021
Slower vs Faster Intravenous Fluid Bolus Rates and Mortality in Critically Ill Patients-Reply
Fernando G Zampieri, Alexandre B Cavalcanti
Journal of Thoracic Disease
|
March 12, 2026
Clinical and methodological considerations from the RENOVATE trial
Israel S Maia, Alexandre B Cavalcanti
JAMA
|
January 22, 2020
Hydroxyethyl Starch for Fluid Replacement Therapy in High-Risk Surgical Patients: Context and Caution
Fernando G Zampieri, Alexandre B Cavalcanti
JAMA
|
August 24, 2016
Quality Improvement Intervention and Mortality of Critically Ill Patients--Reply
Alexandre B Cavalcanti, Flávia R Machado, Otávio Berwanger
The New England Journal of Medicine
|
December 2, 2020
Hydroxychloroquine with or without Azithromycin in Covid-19. Reply
Alexandre B Cavalcanti, Otávio Berwanger, Fernando G Zampieri
American Journal of Respiratory and Critical Care Medicine
|
November 30, 2022
Reply to Gueret: Did Balanced Crystalloids Really Decrease Mortality in Patients with Sepsis?
Fernando G Zampieri, Flavia R Machado, Alexandre B Cavalcanti
Current Opinion in Critical Care
|
September 30, 2016
Fluid composition and acute kidney injury
Fernando G Zampieri, Alexandre B Libório, Alexandre B Cavalcanti
Current Opinion in Critical Care
|
August 16, 2024
Subgroup analyses and heterogeneity of treatment effects in randomized trials: a primer for the clinician
Alexandra B Spicer, Alexandre B Cavalcanti, Fernando G Zampieri
JAMA
|
April 27, 2016
Acute Kidney Injury With Buffered Crystalloids vs Saline Among ICU Patients
Alexandre B Cavalcanti, Lucas P Damiani, Fernando A Bozza
Thorax
|
May 27, 2025
Addressing heterogeneous treatment effects in acute care syndromes: principles and practical considerations
Fernando G Zampieri, Sean M Bagshaw, Alexandre B Cavalcanti
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
JAMA
|
December 14, 2021
Slower vs Faster Intravenous Fluid Bolus Rates and Mortality in Critically Ill Patients-Reply
Fernando G Zampieri, Alexandre B Cavalcanti
Journal of Thoracic Disease
|
March 12, 2026
Clinical and methodological considerations from the RENOVATE trial
Israel S Maia, Alexandre B Cavalcanti
JAMA
|
January 22, 2020
Hydroxyethyl Starch for Fluid Replacement Therapy in High-Risk Surgical Patients: Context and Caution
Fernando G Zampieri, Alexandre B Cavalcanti
JAMA
|
August 24, 2016
Quality Improvement Intervention and Mortality of Critically Ill Patients--Reply
Alexandre B Cavalcanti, Flávia R Machado, Otávio Berwanger
The New England Journal of Medicine
|
December 2, 2020
Hydroxychloroquine with or without Azithromycin in Covid-19. Reply
Alexandre B Cavalcanti, Otávio Berwanger, Fernando G Zampieri
American Journal of Respiratory and Critical Care Medicine
|
November 30, 2022
Reply to Gueret: Did Balanced Crystalloids Really Decrease Mortality in Patients with Sepsis?
Fernando G Zampieri, Flavia R Machado, Alexandre B Cavalcanti
Current Opinion in Critical Care
|
September 30, 2016
Fluid composition and acute kidney injury
Fernando G Zampieri, Alexandre B Libório, Alexandre B Cavalcanti
Current Opinion in Critical Care
|
August 16, 2024
Subgroup analyses and heterogeneity of treatment effects in randomized trials: a primer for the clinician
Alexandra B Spicer, Alexandre B Cavalcanti, Fernando G Zampieri
JAMA
|
April 27, 2016
Acute Kidney Injury With Buffered Crystalloids vs Saline Among ICU Patients
Alexandre B Cavalcanti, Lucas P Damiani, Fernando A Bozza
Thorax
|
May 27, 2025
Addressing heterogeneous treatment effects in acute care syndromes: principles and practical considerations
Fernando G Zampieri, Sean M Bagshaw, Alexandre B Cavalcanti
Page
of 9